Brief: Kinnate Biopharma Prices Its IPO Of 12 Mln Common Shares At $20/Share
Dec 2 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA ANNOUNCES PRICING OF INITIAL PUBLIC
OFFERING
* KINNATE BIOPHARMA - PRICING OF ITS IPO OF 12 MILLION
SHARES OF
ITS COMMON STOCK AT $20.00 PER SHARE
Source text for Eikon: ID:nGNXVMykC
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview